Pharmaceutical Preparations · U0 · CIK 1631574
Wave Life Sciences develops RNA medicines to treat rare and common disorders by targeting RNA with innovative chemistry
Comparable business profile · signals at a glance
In the 90 days to Mar 30, 2026: 1 insider bought $54.6M · 4 sold $908K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 30, 2026 | Ra Capital Management, L.P.Director,TenPercentOwner | Buy | 971,091 | $6.50 | $6.3M |
| Mar 27, 2026 | Ra Capital Management, L.P.Director,TenPercentOwner | Buy | 2,495,623 | $6.43 | $16.0M |
| Mar 26, 2026 | Ra Capital Management, L.P.Director,TenPercentOwner | Buy | 4,954,558 | $6.06 | $30.0M |
| Mar 26, 2026 | Ra Capital Management, L.P.Director,TenPercentOwner | Buy | 351,224 | $6.38 | $2.2M |
| Feb 26, 2026 | Francis ChrisSee Remarks | Sell | 17,900 | $15.09 | $270K |
| Feb 26, 2026 | Francis ChrisSee Remarks | Sell | 15,294 | $15.00 | $229K |
| Feb 9, 2026 | Bolno PaulPresident and CEO | Sell | 10,480 | $13.45 | $141K |
| Feb 9, 2026 | Moran KyleChief Financial Officer | Sell | 3,588 | $13.45 | $48K |
| Feb 9, 2026 | Vargeese ChandraSee Remarks | Sell | 3,228 | $13.45 | $43K |
| Feb 9, 2026 | Francis ChrisSee Remarks | Sell | 1,883 | $13.45 | $25K |
| Jan 2, 2026 | Francis ChrisSee Remarks | Sell | 8,080 | $15.92 | $129K |
| Jan 2, 2026 | Francis ChrisSee Remarks | Sell | 1,295 | $16.70 | $22K |
| Dec 11, 2025 | Gsk PlcTenPercentOwner | Buy | 1,470,000 | $19.00 | $27.9M |
| Dec 9, 2025 | Moran KyleChief Financial Officer | Sell | 50,000 | $20.03 | $1.0M |
| Dec 9, 2025 | Moran KyleChief Financial Officer | Sell | 36 | $20.25 | $729 |
| Dec 8, 2025 | Francis ChrisSee Remarks | Sell | 122,349 | $14.20 | $1.7M |
| Dec 8, 2025 | Francis ChrisSee Remarks | Sell | 107,400 | $14.56 | $1.6M |
| Dec 8, 2025 | Moran KyleChief Financial Officer | Sell | 50,000 | $18.00 | $900K |
| Dec 8, 2025 | Francis ChrisSee Remarks | Sell | 50,000 | $16.00 | $800K |
| Dec 8, 2025 | Moran KyleChief Financial Officer | Sell | 60,000 | $13.20 | $792K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.